Dimple Patel

497 total citations
20 papers, 343 citations indexed

About

Dimple Patel is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Geriatrics and Gerontology. According to data from OpenAlex, Dimple Patel has authored 20 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 4 papers in Molecular Biology and 3 papers in Geriatrics and Gerontology. Recurrent topics in Dimple Patel's work include Pharmaceutical studies and practices (6 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and RNA modifications and cancer (2 papers). Dimple Patel is often cited by papers focused on Pharmaceutical studies and practices (6 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and RNA modifications and cancer (2 papers). Dimple Patel collaborates with scholars based in United States, India and United Kingdom. Dimple Patel's co-authors include Jeffrey S. Barrett, Jeffrey Skolnik, Peter C. Adamson, Bhuvana Jayaraman, H. Vernon Roohk, Mahesh Narayan, Athena F. Zuppa, Adam J. Rose, Elaine M. Hylek and Beth Ann Petrakis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Computer Methods and Programs in Biomedicine.

In The Last Decade

Dimple Patel

17 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dimple Patel United States 9 71 64 64 63 38 20 343
Mary E. Ritchey United States 13 41 0.6× 36 0.6× 91 1.4× 69 1.1× 26 0.7× 32 564
Timothy Goggin Switzerland 13 59 0.8× 108 1.7× 238 3.7× 39 0.6× 12 0.3× 22 690
Prasun Subedi United States 10 25 0.4× 60 0.9× 80 1.3× 30 0.5× 34 0.9× 22 434
Anja Schiel Norway 13 44 0.6× 150 2.3× 35 0.5× 125 2.0× 7 0.2× 24 582
Elizabeth M. Garry United States 14 54 0.8× 64 1.0× 34 0.5× 131 2.1× 15 0.4× 32 614
Mugdha Gokhale United States 14 24 0.3× 73 1.1× 122 1.9× 79 1.3× 9 0.2× 31 603
Jared Spitz United States 7 71 1.0× 69 1.1× 58 0.9× 31 0.5× 11 0.3× 25 333
J. L. Haybittle United Kingdom 9 25 0.4× 28 0.4× 59 0.9× 137 2.2× 15 0.4× 11 460
Anna McGlothlin United States 9 15 0.2× 52 0.8× 189 3.0× 92 1.5× 10 0.3× 16 504
Frédéric Balusson France 14 22 0.3× 43 0.7× 58 0.9× 12 0.2× 10 0.3× 38 469

Countries citing papers authored by Dimple Patel

Since Specialization
Citations

This map shows the geographic impact of Dimple Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimple Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimple Patel more than expected).

Fields of papers citing papers by Dimple Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimple Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimple Patel. The network helps show where Dimple Patel may publish in the future.

Co-authorship network of co-authors of Dimple Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Dimple Patel. A scholar is included among the top collaborators of Dimple Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimple Patel. Dimple Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Patel, Dimple, et al.. (2025). LncRNA-miRNA-mRNA regulatory axes as potential biomarkers in cervical cancer: a comprehensive overview. Molecular Biology Reports. 52(1). 110–110. 2 indexed citations
3.
Patel, Dimple, et al.. (2024). Heavily treatment-experienced patients with HIV: are new mechanisms of action enough?. Journal of International Medical Research. 52(12). 3649362811–3649362811.
4.
Patel, Dimple, et al.. (2023). Deciphering the role of MitomiRs in cancer: A comprehensive review. Mitochondrion. 70. 118–130. 8 indexed citations
5.
Patel, Dimple, et al.. (2023). Molecular and Cellular Advances in Gynecologic Cancer Research. SHILAP Revista de lepidopterología. 50(6). 1 indexed citations
6.
Agrawal, Sanjit Kumar, et al.. (2023). Oncologic safety of breast conservation following NACT in women with locally advanced breast cancer. ecancermedicalscience. 17. 1554–1554. 3 indexed citations
7.
Patel, Dimple, et al.. (2023). Intermittent fasting in health and disease. Archives of Physiology and Biochemistry. 130(6). 755–767. 7 indexed citations
8.
Patel, Dimple, et al.. (2022). The role of tumor-educated platelets in ovarian cancer: A comprehensive review and update. Pathology - Research and Practice. 241. 154267–154267. 7 indexed citations
9.
Sharma, Khushboo, et al.. (2020). A research study on investors behaviour regarding choice of asset allocation of teaching staff. International Journal on Integrated Education. 3(2). 68–77. 1 indexed citations
10.
Patel, Dimple, et al.. (2019). Successful use of fondaparinux in the setting of heparin‐induced thrombocytopenia with thrombosis confirmed by serotonin‐release assay and Factor V Leiden. Journal of Clinical Pharmacy and Therapeutics. 44(5). 809–812. 3 indexed citations
11.
Roohk, H. Vernon, et al.. (2017). Glycated albumin (GA) and inflammation: role of GA as a potential marker of inflammation. Inflammation Research. 67(1). 21–30. 25 indexed citations
12.
Barrett, Jeffrey S., et al.. (2013). Risk Assessment of Drug Interaction Potential and Concomitant Dosing Pattern on Targeted Toxicities in Pediatric Cancer Patients. The AAPS Journal. 15(3). 775–786. 14 indexed citations
13.
14.
Rose, Adam J., et al.. (2012). Organizational Characteristics of High‐ and Low‐Performing Anticoagulation Clinics in the Veterans Health Administration. Health Services Research. 47(4). 1541–1560. 39 indexed citations
15.
Barrett, Jeffrey S., Mahesh Narayan, Dimple Patel, Athena F. Zuppa, & Peter C. Adamson. (2011). Prescribing habits and caregiver satisfaction with resources for dosing children: Rationale for more informative dosing guidance. BMC Pediatrics. 11(1). 25–25. 12 indexed citations
16.
Barrett, Jeffrey S., Bhuvana Jayaraman, Dimple Patel, & Jeffrey Skolnik. (2008). A SAS-based solution to evaluate study design efficiency of phase I pediatric oncology trials via discrete event simulation. Computer Methods and Programs in Biomedicine. 90(3). 240–250. 10 indexed citations
17.
Barrett, Jeffrey S., Dimple Patel, Bhuvana Jayaraman, Mahesh Narayan, & Athena F. Zuppa. (2008). Key Performance Indicators for the Assessment of Pediatric Pharmacotherapeutic Guidance. The Journal of Pediatric Pharmacology and Therapeutics. 13(3). 141–155. 4 indexed citations
18.
Skolnik, Jeffrey, Jeffrey S. Barrett, Bhuvana Jayaraman, Dimple Patel, & Peter C. Adamson. (2008). Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six Design. Journal of Clinical Oncology. 26(2). 190–195. 168 indexed citations
19.
Zuppa, Athena F., Bhuvana Jayaraman, Dimple Patel, et al.. (2007). An Informatics Approach to Assess Pediatric Pharmacotherapy: Design and Implementation of a Hospital Drug Utilization System. The Journal of Clinical Pharmacology. 47(9). 1172–1180. 8 indexed citations
20.
Zuppa, Athena F., Peter C. Adamson, John Mondick, et al.. (2005). Drug Utilization in the Pediatric Intensive Care Unit: Monitoring Prescribing Trends and Establishing Prioritization of Pharmacotherapeutic Evaluation of Critically Ill Children. The Journal of Clinical Pharmacology. 45(11). 1305–1312. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary E. Ritchey Breakdown of academic impact, for papers by Timothy Goggin Breakdown of academic impact, for papers by Prasun Subedi Breakdown of academic impact, for papers by Anja Schiel Breakdown of academic impact, for papers by Elizabeth M. Garry Breakdown of academic impact, for papers by Mugdha Gokhale Breakdown of academic impact, for papers by Jared Spitz Breakdown of academic impact, for papers by J. L. Haybittle Breakdown of academic impact, for papers by Anna McGlothlin Breakdown of academic impact, for papers by Frédéric Balusson
Rankless by CCL
2026